Drug Recall: Pain Relief Gel Due to Manufacturing Practice Deviations
Doctor D. Schwab Clinical Weh Weh Natural Pain Relief Gel is being recalled due to Current Good Manufacturing Practice deviations. The product was distributed in California, Colorado, Florida, Puerto Rico, and Washington.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations with no reported illnesses, injuries, or specific hazard identified in the source material. The recall was initiated voluntarily by the manufacturer, consistent with a moderate-severity precautionary manufacturing recall.
Plain-English summary
Doctor D. Schwab Clinical Weh Weh Natural Pain Relief Gel with Menthol and Arnica (5% menthol, 4.2 oz./120 g tubes) is being recalled due to Current Good Manufacturing Practice (CGMP) deviations discovered during manufacturing. The affected product is lot D53081, which expires July 31, 2026, with NDC 35192-020-02.
The product was distributed in California, Colorado, Florida, Puerto Rico, and Washington. A total of 810 tubes are involved in the recall.
CA BOTANA International, Inc., the manufacturer, initiated this voluntary recall on October 10, 2025. The FDA center classified the recall on November 26, 2025.
Consumers who have purchased this product should stop using it and contact the manufacturer for instructions on how to return or dispose of the affected lot.
The recalled product
- Product
- Doctor D. Schwab Clinical Weh Weh Natural Pain Relief Gel with Menthol and Arnica, Menthol 5%, 4.2 oz./120 g per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92121. NDC: 35192-020-02
- Manufacturer
- CA BOTANA International, Inc.
- Category
- Drug — Topical Pain Relief
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot D53081
- exp 7/31/2026
Distribution
Distributed in 5 states:
- CA
- CO
- FL
- PR
- WA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27